Clinical Trial Update: Prospective Evaluation of Intrathecal Targeted Drug Delivery for Cancer Associated Pain

View source ↗

Summary

The prospective study of intrathecal targeted drug delivery for cancer-associated pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Neuropathic Pain
• Pain

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Cancer Pain, Chronic Pain | Status: COMPLETED